News
IRADIMED CORPORATION to Hold 2023 Third Quarter Financial Results Conference Call on November 3rd
WINTER SPRINGS, Fla., Oct. 26, 2023 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 third quarter financial results before the market opens on Friday, November 3rd. IRADIMED management will host a conference call the same...
IRADIMED CORPORATION to Participate at Upcoming Investor Conferences
WINTER SPRINGS, Fla., Sept. 06, 2023 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) today announced that the Company will be participating in two upcoming investor conferences. Iradimed management is scheduled to participate in investor meetings at the H.C....
IRADIMED CORPORATION Announces Second Quarter 2023 Financial Results
Reports record revenue of $16.1 million for the second quarter of 2023GAAP diluted EPS of $0.33 and non-GAAP diluted EPS of $0.36Operating income was $5.0 million and increased by 19%Announces third quarter and full year 2023 financial guidance WINTER SPRINGS, Fla.,...
IRADIMED CORPORATION to Hold 2023 Second Quarter Financial Results Conference Call on August 3rd
WINTER SPRINGS, Fla., July 27, 2023 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 second quarter financial results before the market opens on Thursday, August 3rd. Iradimed management will host a conference call the same...
IRADIMED CORPORATION Named a 2023 Best Small Company in America by Forbes
WINTER SPRINGS, Fla., May 10, 2023 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD), was recently named on Forbes' latest list of America's Best Small Companies for 2023. Iradimed is a leader in the development of innovative magnetic resonance imaging ("MRI")...
IRADIMED CORPORATION Announces First Quarter 2023 Financial Results
Reports record revenue of $15.5 million for the first-quarter quarter of 2023 GAAP diluted EPS of $0.27 and non-GAAP diluted EPS of $0.30 Operating income was $4.0 million and increased by 30% Announces second quarter 2023 financial guidance and increases full-year...
IRADIMED CORPORATION to Hold 2023 First Quarter Financial Results Conference Call on May 4th
WINTER SPRINGS, Fla., April 27, 2023 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 first quarter financial results before the market opens on Thursday, May 4th. Iradimed management will host a conference call the same...
IRADIMED CORPORATION To Present at the 35th Annual Roth Conference
WINTER SPRINGS, Fla., March 06, 2023 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) today announced that Roger Susi, President and Chief Executive Officer of the Company, will be presenting at the 35th Annual Roth Conference in Laguna Niguel, CA. Mr. Susi is...
IRADIMED CORPORATION Issues Urgent Medical Device Correction
Letter Notifying Customers of Potential Issues with MRidium 1057 MRI Syringe Adapter SetWINTER SPRINGS, Fla., Feb. 24, 2023 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) issued an Urgent Medical Device Correction Letter to notify affected customers of a...
IRADIMED CORPORATION Announces Fourth Quarter and Full Year 2022 Financial Results and Announces Special Cash Dividend
Reports fourth quarter 2022 revenue of $14.9 million, GAAP diluted EPS of $0.29 and non-GAAP diluted EPS of $0.32.Reports full-year 2022 revenue of $53.3 million, GAAP diluted EPS of $1.02 and non-GAAP diluted EPS of $1.10.The Board of Directors approved a special...